Enhancing Referrals to Child and Adolescent Mental Health Services: EnCAMHS (EnCAMHS)

Enhancing CAMHS Referrals: EnCAMHS

Our aim is to find low-cost and widely reusable mechanisms to reduce inappropriate referrals. Our key objectives are:

Engage with key stakeholders to identify problems with making appropriate referrals Analyse CAMHS referral data to understand and identify problems (quantitatively) Identify requirements for sustainable solutions Explore with key stakeholders how we can improve the referral process Identify how the best proposed solutions could be embedded within routine CAMHS referral pathways

Study Overview

• Status: Completed
• Conditions: Mental Health Issue
• Intervention / Treatment: Other: Focus Groups

Detailed Description

The Investigators shall conduct a series of focus groups with key stakeholders involved in the referral to CAMHS process; children and young people (CYP), parents/carers, key referrers, CAMHS professionals in order to better understand the challenges that exist with the current referral process. Following this, the Investigators will conduct further focus groups with the key stakeholders above, in which they will suggest sustainable solutions to the problems that have been identified.

The Investigators shall then identify how the propose solutions can be embedded into routine CAMHS referral pathways.

• Study Type: Observational
• Enrollment (Actual): 110

Contacts and Locations

Study Locations

• United Kingdom
  • Manchester, United Kingdom
    • University of Manchester

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years and older (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Anyone aged 16 and above who has been involved in the CAMHS referral pathway

Description

Inclusion Criteria:

• Aged 16 years and above
• have experience of CAMHS referral pathway

Exclusion Criteria:

• younger than 16 years

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Other

Number of groups / cohorts

4

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Children and young people (CYP); Children and young people who have been referred to CAMHS	Other: Focus Groups; Focus Groups
Parents/carers; Parents/carers of CYP who have been referred to CAMHS	Other: Focus Groups; Focus Groups
Key referrers; Key referrers (e.g. Teachers, GPs, SENCOs, Social Workers) who have referred CYP to CAMHS	Other: Focus Groups; Focus Groups
CAMHS Professionals; CAMHS Professionals who have received referrals to CAMHS	Other: Focus Groups; Focus Groups

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Solutions to enhance the referral process for CAMHS	Solutions to help improve the referrals into CAMHS, using data collected during focus groups	By end of study - within 1 year

Collaborators and Investigators

• Sponsor: Greater Manchester Mental Health NHS Foundation Trust
• Collaborators: Manchester University NHS Foundation Trust; University of Manchester; Anna Freud National Centre for Children and Families; Northumberland, Tyne and Wear NHS Foundation Trust; Pennine Care NHS Foundation Trust; McPin Foundation; MQ Mental Health; 42nd Street

Study record dates

Study Major Dates

• Study Start (Actual): November 1, 2021
• Primary Completion (Actual): May 1, 2022
• Study Completion (Actual): June 30, 2023

Study Registration Dates

• First Submitted: April 28, 2022
• First Submitted That Met QC Criteria: June 7, 2022
• First Posted (Actual): June 9, 2022

Study Record Updates

• Last Update Posted (Estimated): February 28, 2024
• Last Update Submitted That Met QC Criteria: February 27, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: NIHR131379

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: We will not be sharing IPD

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No